Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000212419 | SCV000167687 | benign | not specified | 2014-01-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000132152 | SCV000187225 | likely benign | Hereditary cancer-predisposing syndrome | 2015-03-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000212419 | SCV000311767 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Counsyl | RCV000409756 | SCV000488885 | likely benign | Familial cancer of breast | 2016-07-11 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000132152 | SCV000684640 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000409756 | SCV002443925 | benign | Familial cancer of breast | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000212419 | SCV004024660 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003492568 | SCV004240452 | benign | Breast and/or ovarian cancer | 2022-08-24 | criteria provided, single submitter | clinical testing | |
Clinical Genetics Laboratory, |
RCV001795226 | SCV002034326 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001795226 | SCV002035217 | likely benign | not provided | no assertion criteria provided | clinical testing |